| (Mark One) |   |                                                                                     |
|------------|--------|------------------------------------------------------------------------------------------|
|       |   |                                                                                     |
| þ     |   | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

|   |   |                                                                                      |
|--------|--------|-------------------------------------------------------------------------------------------|
| o      |   | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

| ACCELERATED ACQUISITIONS XXI, INC.                           |
|--------------------------------------------------------------|
| (Exact name of registrant as specified in its charter)  |

| Delaware                                       |   | 45-4511132                        |
|------------------------------------------------|--------|-----------------------------------|
| (State or other jurisdiction of incorporation) |   | (IRS Employer Identification No.) |
|                                           |   |                              |

| Large Accelerated Filer o |   | Accelerated Filer o |   | Non-Accelerated Filer o |   | Smaller Reporting Company þ |
|---------------------------|--------|---------------------|--------|-------------------------|--------|----------------------------------|
|                      |   |                |   |                    |   |                             |

----

|                                  |                                                                                                                                             |   | Page(s) |   |
|---------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------|--------|
| PART I – FINANCIAL INFORMATION: |                                                                                                                                             |   |    |
|                                  |                                                                                                                                             |   |    |   |
| Item 1.                               | Financial Statements (unaudited):                                                                                                                |   |    | 3      |   |
|                                  |                                                                                                                                             |   |    |   |   |
|                                  | Balance Sheets as of June 30, 2012 (unaudited) and March 31, 2012 (audited)                                                                      |   |    | 3      |   |
|                                  |                                                                                                                                             |   |    |   |   |
|                                  | Statements of Operations for the three months ended June 30, 2012 and period from inception (February 6, 2012) through June 30, 2012 (unaudited) |   |    | 4      |   |
|                                  |                                                                                                                                             |   |    |   |   |
|                                  | Statements of Cash Flows for the three months ended June 30, 2012 and period from inception (February 6, 2012) through June 30, 2012 (unaudited) |   |    | 5      |   |
|                                  |                                                                                                                                             |   |    |   |   |
|                                  | Notes to Financial Statements (unaudited)                                                                                                        |   |    | 7      |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 2.                               | Management's Discussion and Analysis of Financial Condition and Results of Operations                                                            |   |    | 11     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 3.                               | Quantitative and Qualitative Disclosures About Market Risk                                                                                       |   |    | 12     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 4T                               | Controls and Procedures                                                                                                                          |   |    | 13     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| PART II – OTHER INFORMATION:    |                                                                                                                                             |   |    |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 1.                               | Legal Proceedings                                                                                                                                |   |    | 13     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 1A                               | Risk Factors                                                                                                                                     |   |    | 13     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 2.                               | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                      |   |    | 13     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 3.                               | Defaults Upon Senior Securities                                                                                                                  |   |    | 13     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 4.                               | (Reserved and Removed)                                                                                                                           |   |    | 13     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 5.                               | Other Information                                                                                                                                |   |    | 13     |   |
|                                  |                                                                                                                                             |   |    |   |   |
| Item 6.                               | Exhibits                                                                                                                                         |   |    | 14     |   |
|                                  |                                                                                                                                             |   |    |   |   |
|                                  | Signatures                                                                                                                                       |   |    | 15     |   |

----

|                                                                                                                                             |   | June 30,    |    |   | March 31, |   |
|--------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------|---------|--------|-----------|--------|
|                                                                                                                                             |   | 2012        |    |   | 2012      |   |
|                                                                                                                                             |   | (Unaudited) |    |   | (Audited) |   |
| ASSETS                                                                                                                                           |   |        |    |   |      |   |   |   |
| Current assets:                                                                                                                                  |   |        |    |   |      |   |   |   |
|         Cash and cash equivalents                                                                        |   | $           | 200     |   |      | $      | 200 |   |
|                                                                                                                                             |   |        |    |   |      |   |
|                                                                                                                                             |   |        |    |   |      |   |   |   |
|                                                                                                                                             |   | $           | 200     |   |      | $      | 200 |   |
|                                                                                                                                             |   |        |    |   |      |   |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT                                                                                                      |   |        |    |   |      |   |   |   |
|        Current liabilities:                                                                                   |   |        |    |   |      |   |   |   |
|        Accrued expenses due to founder                                                                        |   | $           | 1,800   |   |      | $      | 0 |   |
|                                                                                                                                             |   |        |    |   |      |   |
|        Total liabilities                                                                                      |   |        | 1,800   |   |      |   | 0 |   |
|                                                                                                                                             |   |        |    |   |      |   |
|        Commitments and contingencies                                                                          |   |        |    |   |      |   |   |   |
|                                                                                                                                             |   |        |    |   |      |   |   |   |
|        Stockholders’ deficit:                                                                           |   |        |    |   |      |   |   |   |
|         Preferred stock, $0.0001 par value, 10,000,000 shares authorized; none issued or outstanding     |   |        | — |   |      |   | — |   |
|        Common stock, $0.0001 par value, 100,000,000 shares authorized,5,000,000 shares issued and outstanding |   |        | 500     |   |      |   | 500 |   |
|        Additional paid-in capital                                                                             |   |        | 1,500   |   |      |   | 1,500 |   |
|        Accumulated deficit                                                                                    |   |        | (3,600  | )      |      |   | (1,800 | ) |
|                                                                                                                                             |   |        |    |   |      |   |
|        Total stockholders’ deficit                                                                      |   |        | (1,600  | )      |      |   | - |   |
|                                                                                                                                             |   |        |    |   |      |   |
|                                                                                                                                             |   | $           | 200     |   |      | $      | 200 |   |

----

|                                                                                                 |   | Three months endedJune 30, 2012 |    |   | Inception(February 6, 2012) throughJune 30, 2012(Cumulative) |   |
|------------------------------------------------------------------------------------------------------|--------|---------------------------------|---------|--------|--------------------------------------------------------------|--------|
|                                                                                                 |   | (Unaudited)                     |    |   | (Unaudited)                                                  |   |
|                                                                                                 |   |                            |    |   |                                                         |   |   |   |
|        Revenues                                                   |   | $                               | — |   |                                                         | $      | — |   |
|                                                                                                 |   |                            |    |   |                                                         |   |
|        Operating expenses                                         |   |                            |    |   |                                                         |   |   |   |
|        General and administrative                                 |   |                            | 1,800   |   |                                                         |   | 3,600 |   |
|                                                                                                 |   |                            |    |   |                                                         |   |
|        Net loss                                                        |   | $                               | (1,800  | )      |                                                         | $      | (3,600 | ) |
|                                                                                                 |   |                            |    |   |                                                         |   |   |   |
|        Basic and diluted net loss per share                       |   | $                               | (0.00   | )      |                                                         |   |   |   |
|                                                                                                 |   |                            |    |   |                                                         |   |
|        Shares used in basic and diluted net loss per share calculation |   |                            | 5,000   |   |                                                         |   |   |   |

----

|                                                                                                                     |   | Common Stock |      |   | AdditionalPaid-InCapital |   |    | AccumulatedDeficit |   |   | AccumulatedOtherComprehensiveIncome |   |   | TotalStockholders’Equity |    |
|--------------------------------------------------------------------------------------------------------------------------|--------|--------------|-----------|--------|--------------------------|--------|---------|--------------------|--------|--------|-------------------------------------|--------|--------|--------------------------------|---------|
|     Balance prior to inception                                                                       |   |         | —   |   |                     | $      | — |               |   | $      | —                             |   |   | $                              | — |   |   | $ | — |   |   | $ | — |   |
|     Issuance of common stock to founder for cash                                                     |   |         | 5,000,000 |   |                     |   | 500     |               |   |   | 1,500                               |   |   |                           | — |   |   |   | — |   |   |   | 2,000 |   |
| Net loss / comprehensive loss                                                                                            |   |         | —   |   |                     |   | — |               |   |   | —                             |   |   |                           | (1,800  | ) |   |   | — |   |   |   | (1,800 | ) |
|    Balances at March 31, 2012                                                                             |   |         | 5,000,000 |   |                     |   | 500     |               |   |   | 1,500                               |   |   |                           | (1,800  | ) |   |   | — |   |   |   | 200 |   |
|                                                                                                                     |   |         |      |   |                     |   |    |               |   |   |                                |   |   |                           |    |   |   |   |   |   |   |   |   |   |
|     Net loss / comprehensive loss                                                                    |   |         | —   |   |                     |   | — |               |   |   |                                |   |   |                           | (1,800  | ) |   |   | — |   |   |   | (1,800 | ) |
|     Stock-based compensation expense         included in net loss |   |         | —   |   |                     |   | — |               |   |   |                                |   |   |                           | — |   |   |   | — |   |   | __ |   |
|     Balances at June 30, 2012                                                                        |   |         | 5,00,000  |   |                     | $      | 500     |               |   | $      | 1,500                               |   |   | $                              | (3,600  | ) |   | $ | — |   |   | $ | (1,600 | ) |

----

|                                                                                                                  |   | Three months endedJune 30, 2012 |    |   | Inception (February 6, 2012) throughJune 30, 2012(Cumulative) |   |
|-----------------------------------------------------------------------------------------------------------------------|--------|---------------------------------|---------|--------|---------------------------------------------------------------|--------|
|        OPERATING ACTIVITIES:                                                       |   |                            |    |   |                                                          |   |
|        Net loss                                                                         |   | $                               | (1,800  | )      |                                                          |   | (3,600 | ) |
|        Adjustments to reconcile net loss to net cash used in operating activities: |   |                            |    |   |                                                          |   |   |   |
|        Increase in accrued expenses due to founder                                 |   |                            | 1,800   |   |                                                          |   | 1,800 |   |
|         Stock-based compensation                                              |   |                            | ---     |   |                                                          |   | ---- |   |
|                                                                                                                  |   |                            |    |   |                                                          |   |   |   |
|         Net cash used in operating activities                                 |   |                            | (1,800  | )      |                                                          |   | (3,600 | ) |
|                                                                                                                  |   |                            |    |   |                                                          |   |   |   |
|        FINANCING ACTIVITIES:                                                       |   |                            |    |   |                                                          |   |   |   |
|        Proceeds from the issuance of common stock                                  |   |                            | — |   |                                                          |   | 2,000 |   |
|                                                                                                                  |   |                            |    |   |                                                          |   |   |   |
|        Net increase in cash and cash equivalents                                   |   |                            | — |   |                                                          |   | 200 |   |
|                                                                                                                  |   |                            |    |   |                                                          |   |   |   |
|        Cash and equivalents at beginning of period                                 |   |                            | 200     |   |                                                          |   | — |   |
|                                                                                                                  |   |                            |    |   |                                                          |   |   |   |
| Cash and equivalents at end of period                                                                                 |   | $                               | 200     |   |                                                          |   | 200 |   |

----

| (a) | Organization and Business: |
|-----|----------------------------|

| (b) | Basis of Presentation |
|-----|-----------------------|

| (c) | Use of Estimates: |
|-----|-------------------|

| (d) | Development Stage |
|-----|-------------------|

| (e) | Cash and Cash Equivalents |
|-----|---------------------------|

----

| (f) | Loss per Common Share |
|-----|-----------------------|

----

|                      |   | June 30,2012 |    |   | March 31,2012 |   |
|---------------------------|--------|--------------|---------|--------|---------------|--------|
| Gross deferred tax assets |   | $            | 3,600.  |   |          | $      | 1,800. |   |
| Valuation allowance       |   |         | (3,600) |   |          |   | (1,800) |   |
| Net deferred tax asset    |   | $            | — |   |          | $      | — |   |

----

| Operating activities |   | $      | (3,600) |   |
|----------------------|--------|--------|---------|--------|
| Investing activities |   |   | -       |   |
| Financing activities |   | $      | 3,800   |   |
|                 |   |   |    |   |
| Net effect on cash   |   | $      | 200     |   |

|   | (i)  | filing of reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and |
|--------|------|---------------------------------------------------------------------------------------------------------------|
|   | (ii) | consummating an acquisition.                                                                                  |

----

----

----

| Exhibit No. |   | Description                                                                                                                                                                                                                           |
|-------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|        |   |                                                                                                                                                                                                                                  |
| 31.1        |   | Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012. |
|        |   |                                                                                                                                                                                                                                  |
| 31.2        |   | Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012. |
|        |   |                                                                                                                                                                                                                                  |
| 32.1        |   | Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.                            |
| 101.DEF*    |   | XBRL Taxonomy Extension Definition Linkbase Document*                                                                                                                                                                                 |
| 101.INS*    |   | XBRL Instance Document                                                                                                                                                                                                                |
| 101.SCH*    |   | XBRL Taxonomy Extension Schema Document                                                                                                                                                                                               |
| 101.CAL*    |   | XBRL Taxonomy Extension Calculation Linkbase Document                                                                                                                                                                                 |
| 101.LAB*    |   | XBRL Taxonomy Extension Label Linkbase Document                                                                                                                                                                                       |
| 101.PRE*    |   | XBRL Taxonomy Extension Presentation Linkbase Document                                                                                                                                                                                |
| 101.DEF*    |   | XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                                                                  |

| Dated: August 14, 2012 |                               |                 |   |
|------------------------|------------------------------------|----------------------|--------|
|                   | ACCELERATED ACQUISITIONS XXI, INC. |                 |
|                   |                               |                 |   |
|                   | By:                                | /s/ Timothy J. Neher |   |
|                   | Timothy J. Neher                   |                 |
|                   | President/ CEO                     |                 |

----

| Exhibit No. |   | Description                                                                                                                                                                                                                           |
|-------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|        |   |                                                                                                                                                                                                                                  |
| 31.1        |   | Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012. |
|        |   |                                                                                                                                                                                                                                  |
| 31.2        |   | Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2012. |
|        |   |                                                                                                                                                                                                                                  |
| 32.1        |   | Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002.                            |
| 101.DEF*    |   | XBRL Taxonomy Extension Definition Linkbase Document*                                                                                                                                                                                 |
| 101.INS*    |   | XBRL Instance Document                                                                                                                                                                                                                |
| 101.SCH*    |   | XBRL Taxonomy Extension Schema Document                                                                                                                                                                                               |
| 101.CAL*    |   | XBRL Taxonomy Extension Calculation Linkbase Document                                                                                                                                                                                 |
| 101.LAB*    |   | XBRL Taxonomy Extension Label Linkbase Document                                                                                                                                                                                       |
| 101.PRE*    |   | XBRL Taxonomy Extension Presentation Linkbase Document                                                                                                                                                                                |
| 101.DEF*    |   | XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                                                                  |

----